Erratum: Lung cancer in HIV infection (Clinical Lung Cancer 13:1 (DOI:10.1016/j.cllc.2011.05.005));Lung cancer in HIV infection

Clinical Lung Cancer

Volumn 13, Issue 1, 2012, Pages 6-13

  Mani, Deepthi ^a   Haigentz, Missak ^b   Aboulafia, David M ^c,d  

^a SACRED HEART MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c VIRGINIA MASON MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

AIDS; HAART; HIV; Non Hodgkin lymphoma

Indexed keywords

AMFEBUTAMONE; ANTINEOPLASTIC AGENT; CARBOPLATIN; EFAVIRENZ; MYC PROTEIN; NELFINAVIR; NICOTINE; PACLITAXEL; PEMETREXED; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P43; PROTEINASE INHIBITOR; RITONAVIR; TRANSACTIVATOR PROTEIN; VARENICLINE; VORINOSTAT;

ABSENCE OF SIDE EFFECTS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RISK; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LIPID PEROXIDATION; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG INFECTION; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; METASTASIS; MULTICENTER STUDY (TOPIC); NICOTINE REPLACEMENT THERAPY; NONHUMAN; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; RECURRENT INFECTION; REVIEW; SMOKING CESSATION; SOLID TUMOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; THORAX RADIOGRAPHY; TOBACCO DEPENDENCE; VIRUS LOAD;

EID: 84855714034     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2012.01.001     Document Type: Erratum

References (116)

1. A. Mocroft, B. Ledergerber, C. Katlama Decline in the AIDS and death rates in the EuroSIDA study: an observational study Lancet 362 2003 22 29 (Pubitemid 36835816)
2. F.J. Palella Jr, K.M. Delaney, A.C. Moorman Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV Outpatient Study Investigators N Engl J Med 338 1998 853 860 (Pubitemid 28135961)
3. M.S. Shiels, S.R. Cole, G.D. Kirk A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals J Acquir Immune Defic Syndr 52 2009 611 622
4. E. Schneider, S. Whitmore, K.M. Glynn Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years - United States, 2008 MMWR Recomm Rep 57 RR-10 2008 1 12
5. L. Pantanowitz, B.J. Dezube Evolving spectrum and incidence of non-AIDS-defining malignancies Curr Opin HIV AIDS 4 2009 27 34
6. M. Haigentz Aerodigestive cancers in HIV infection Curr Opin Oncology 17 2005 474 478
7. E.A. Engels Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities AIDS 23 2009 875 885
8. M.S. Shiels, R.M. Pfeiffer, M.H. Gail Cancer burden in the HIV-infected population in the United States J Natl Cancer Inst 103 2011 753 762
9. D.M. Parkin, F. Bray, J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74
10. E.A. Engels, J.J. Goedert Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future J Natl Cancer Inst 97 2005 407 409 (Pubitemid 40528595)
11. E.A. Engels, R.M. Pfeiffer, J.J. Goedert Trends in cancer risk among people with AIDS in the United States 19802002 AIDS 20 2006 1645 1654 (Pubitemid 44162407)
12. A.K. Chaturvedi, R.M. Pfeiffer, L. Chang Elevated risk of lung cancer among people with AIDS AIDS 21 2007 207 213 (Pubitemid 46036929)
13. M.S. Parker, D.M. Leveno, T.J. Campbell AIDS related bronchogenic carcinoma: fact or fiction? Chest 113 1998 154 161
14. E.A. Engels, M.V. Brock, J. Chen Elevated incidence of lung cancer among HIV-infected individuals J Clin Oncol 24 2006 1383 1388 (Pubitemid 46622002)
15. G.D. Kirk, C. Merlo, P. O' Driscoll HIV infection is associated with an increased risk for lung cancer, independent of smoking Clin Infect Dis 45 2007 103 110 (Pubitemid 46984625)
16. M.S. Shiels, S.R. Cole, S.H. Mehta Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users J Acquir Immune Defic Syndr 55 2010 510 515
17. L.E. Irwin, M.K. Begandy, T.M. Moore Adenosquamous carcinoma of the lung and the acquired immunodeficiency syndrome Ann Intern Med 100 1984 158
18. M. Frisch, R.J. Biggar, E.A. Engels Association of cancer with AIDS related immunosuppression in adults JAMA 285 2001 1736 1745 (Pubitemid 32259908)
19. G.M. Allardice, D.J. Hole, D.H. Brewster Incidence of malignant neoplasms among HIV-infected persons in Scotland Br J Cancer 89 2003 505 507 (Pubitemid 37026434)
20. B. Gallagher, Z. Wang, M.J. Schymura Cancer incidence in New York State acquired immunodeficiency syndrome patients Am J Epidemiol 154 2001 544 556 (Pubitemid 32867954)
21. L. Dal Maso, J. Polesel, D. Serraino Lung cancer in persons with AIDS in Italy, 19851998 AIDS 17 2003 2117 2119 (Pubitemid 37297160)
22. L. Dal Maso, S. Franceschi, J. Polesel Cancer and AIDS registry linkage study Risk of cancer in persons with AIDS in Italy, 1985-1998 Br J Cancer 89 2003 94 100 (Pubitemid 36897942)
23. A. Newnham, J. Harris, H.S. Evans The risk of cancer in HIV-infected people in southeast England: a cohort study Br J Cancer 92 2005 194 200 (Pubitemid 40188455)
24. G.M. Clifford, J. Polesel, M. Rickenbach Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy J Natl Cancer Inst 97 2005 425 432 (Pubitemid 40528605)
25. A.E. Grulich, Y. Li, A. McDonald Rates of nonAIDS-defining cancers in people with HIV infection before and after AIDS diagnosis AIDS 16 2002 1155 1161 (Pubitemid 34533854)
26. D. Serraino, P. Piselli, G. Busnach Immunosuppression and Cancer Study Group Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe Eur J Cancer 43 2007 2117 2123 (Pubitemid 47381577)
27. M. Bower, T. Powles, M. Nelson HIV-related lung cancer in the era of highly active antiretroviral therapy AIDS 17 2003 371 375 (Pubitemid 36230918)
28. M. Herida, M. Mary-Krause, R. Kaphan Incidence of nonAIDS defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virusinfected patients J Clin Oncol 21 2003 3447 3453 (Pubitemid 46594077)
29. J.L. Long, E.A. Engels, R.D. Moore Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals AIDS 22 2008 489 496 (Pubitemid 351317290)
30. M.J. Silverberg, C. Chao, W.A. Leyden HIV infection and the risk of cancers with and without a known infectious cause AIDS 23 2009 2337 2345
31. M.S. Shiels, R.M. Pfeiffer, E.A. Engels Age at cancer diagnosis among persons with AIDS in the United States Ann Intern Med 153 2010 452 460
32. E.A. Engels, R.J. Biggar, H.I. Hall Cancer risk in people infected with human immunodeficiency virus in the United States Int J Cancer 123 2008 187 194 (Pubitemid 351705208)
33. P. Patel, D.L. Hanson, P.S. Sullivan Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003 Ann Intern Med 148 2008 728 736 (Pubitemid 351717418)
34. A.E. Grulich, M.T. van Leeuwen, M.O. Falster Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis Lancet 370 2007 59 67 (Pubitemid 47017468)
35. J.E. Burkhalter, C.M. Springer, R. Chhabra Tobacco use and readiness to quit smoking in low-income HIV-infected persons Nicotine and Tobacco Research 7 2005 511 522 (Pubitemid 41600909)
36. Centers for Disease Control and Prevention Vital Signs: Current Cigarette Smoking Among Adults Aged < 18 YearsUnited States, 2009 Morbidity and Mortality Weekly Report 5 9 2010 1135 1140
37. S.C. Thompson, C. Nanni, A. Levine The stressors and stress of being HIVpositive AIDS Care 8 1996 5 14
38. M.M. Marshall, G.D. Kirk, N.E. Caporaso Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users Addict Behav 36 2011 61 67
39. A.P. Liappis, H. Cohen-Blair, C.A. Reisen et al. Identification of Tobacco Use in HIV-Infected Patients: The Added Role in Screening for Malignancy and Anal Dysplasia 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2010) Boston, MA September 12-15, 2010 Abstract H-224
40. G. D'Jaen, L. Pantanowitz, M. Bower Human immunodeficiency virusassociated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration Clin Lung Cancer 11 2010 396 404
41. A. el-Solh, N.M. Kumar, M.P. Nair An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549 Immunol Invest 26 1997 351 370 (Pubitemid 27184243)
42. M.E. Baker, L. Yan, M.R. Pear Three-dimensional model of human TIP30, a coactivator for HIV-1 Tat-activated transcription, and CC3, a protein associated with metastasis suppression Cell Mol Life Sci 57 2000 851 858 (Pubitemid 30392041)
43. X. Tong, K. Li, Z. Luo Decreased TIP30 expression promotes tumor metastasis in lung cancer Am J Pathol 174 2009 1931 1939
44. I.I. Wistuba, C. Behrens, S. Milchgrub et al. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects JAMA 279 1998 1554 1559 (Pubitemid 28233011)
45. S.B. Gordon, E.N. Janoff, D. Sloper HIV-1 infection is associated with altered innate pulmonary immunity J Infect Dis 192 2005 1412 1416 (Pubitemid 41401155)
46. C. Agostini, R. Sancetta, A. Cerutti Alveolar macrophages as a cell source of cytokine hyperproduction in HIV-related interstitial lung disease J Leukoc Biol 58 1995 495 500
47. J.P. Allard, E. Aghdassi, J. Chau Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection Am J Clin Nutr 67 1998 143 147 (Pubitemid 28037639)
48. W.T. Caiaffa, N.M. Graham, D. Vlahov Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection Am J Epidemiol 138 1993 909 922 (Pubitemid 24002358)
49. E.A. Engels Inflammation in the development of lung cancer: epidemiological evidence Expert Rev Anticancer Ther 8 2008 605 615 (Pubitemid 351818355)
50. F.M. Shebl, E.A. Engels, J.J. Goedert Pulmonary infections and risk of lung cancer among persons with AIDS J Acquir Immune Defic Syndr 55 2010 375 379
51. M. Guiguet, F. Boué, J. Cadranel Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDHANRS CO4): a prospective cohort study Lancet Oncol 10 2009 1152 1159
52. R. Vyzula, S.C. Remick Lung cancer in patients with HIV-infection Lung Cancer 153 1996 325 339 (Pubitemid 26399512)
53. K.S. Sridhar, M.R. Flores, W.A. Raub Jr Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects Chest 102 1992 1704 1708 (Pubitemid 23001213)
54. U. Tirelli, M. Spina, S. Sandri Lung carcinoma in 36 patients with human immunodeficiency virus infection The Italian Cooperative Group on AIDS and Tumors Cancer 88 2000 563 569 (Pubitemid 30056930)
55. M.T. Alshafie, B. Donaldson, S.F. Oluwole Human immunodeficiency virus and lung cancer Br J Surg 84 1997 1068 1071 (Pubitemid 27359475)
56. M.R. Flores, K.S. Sridhar, R.J. Thurer Lung cancer in patients with human immunodeficiency virus infection Am J Clin Oncol 18 1995 59 66
57. J.P. Spano, M.A. Massiani, M. Bentata Lung cancer in patients with HIV infection and review of the literature Med Oncol 21 2004 109 115 (Pubitemid 39108000)
58. M. Ruiz Lung Cancer in HIV-infected patients: the experience of an urban clinic J Int Assoc Physicians AIDS Care (Chic Ill) 9 2010 214 217
59. M.V. Brock, C.M. Hooker, E.A. Engels Delayed diagnosis and elevated mortality in an urban population with HIV and LC: implications for patient care J Acquir Immune Defic Syndr 43 2006 47 55 (Pubitemid 44306487)
60. R. Hakimian, H. Fang, L. Thomas LC in HIV-infected patients in the era of highly active antiretroviral therapy J Thorac Oncol 2 2007 268 272 (Pubitemid 47181707)
61. A. Lavolé, C. Chouad, L. Baudrin Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell LC Lung Cancer 65 2009 345 350
62. G. Jung, J. Chung, J. Shuter Lung cancer in HIV infection: a case series J Clin Oncol 26 2008 15S Abstract 19093
63. J. Cadranel, D. Garfield, A. Lavolé Lung cancer in HIV infected patients: facts, questions and challenges Thorax 61 2006 1000 1008 (Pubitemid 44787172)
64. J. Karp, G. Profeta, P.R. Marantz Lung cancer in patients with immunodeficiency syndrome Chest 103 1993 410 413 (Pubitemid 23070735)
65. M. Bazot, J. Cadranel, A. Khalil Computed tomographic diagnosis of bronchogenic carcinoma in HIV-infected patients Lung Cancer 28 2000 203 209 (Pubitemid 30254228)
66. J.F. Gruden, W.R. Webb, D.C. Yao Bronchogenic carcinoma in 13 patients infected with the human immunodeficiency virus (HIV): clinical and radiographic findings J Thorac Imaging 10 1995 99 105
67. C.S. White, L.B. Haramati, K.H. Elder Carcinoma of the lung in HIV-positive patients: findings on chest radiographs and CT scans Am J Roentgenol 164 1995 593 597
68. S.E. Cotter, P.W. Grigsby, B.A. Siegel FDG-PET/CT in the evaluation of anal carcinoma Int J Radiat Oncol Biol Phys 65 2006 720 725 (Pubitemid 43795859)
69. C. Love, M.B. Tomas, G.G. Tronco FDG PET of infection and inflammation Radiographics 25 2005 1357 1368 (Pubitemid 41695350)
70. P. Bhargava, J.A. Parker, B.J. Dezube Pitfalls of diagnosis based on abnormal flow cytometry and [(18)F]fluorodeoxyglucose positron emission tomography Clin Lymphoma Myeloma 8 2008 117 120 (Pubitemid 351775770)
71. A.J. Alberg, J.M. Samet Epidemiology of lung cancer Chest 123 2003 21S 49S (Pubitemid 36135701)
72. G.C. Persad, R.F. Little, C. Grady Including persons with HIV infection in cancer clinical trials J Clin Oncol 26 2008 1027 1032
73. F. Massera, G. Rocco, G. Rossi Pulmonary resection for lung cancer in HIV-positive patients with low (<200 lymphocytes/mm3) CD4+ count Lung Cancer 29 2000 147 149 (Pubitemid 30645824)
74. T. Powles, C. Thirwell, T. Newsom-Davis Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? Br J Cancer 89 2003 457 459 (Pubitemid 37026424)
75. R.J. Biggar, E.A. Engels, S. Ly Survival after cancer diagnosis in persons with AIDS J Acquir Immune Defic Syndr 39 3 2005 293 299 (Pubitemid 40923208)
76. A. Makinson, J.C. Tenon, S. Eymard-Duvernay et al. Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study J Thorac Oncol 6 2011 1022 1029
77. A. Bazoes, M. Bower, T. Powles Smoke and mirrors: HIV-related lung cancer Curr Opin Oncol 20 2008 529 533
78. A. Antinori, A. Cingolani, L. Alba Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy AIDS 15 2001 1483 1491 (Pubitemid 32744595)
79. A. Rahman, K.R. Korzekwa, J. Grogan Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8 Cancer Res 54 21 1994 5543 5546
80. J.W. Harris, A. Katki, L.W. Anderson Isolation, structural determination, and biological activity of 6 alpha-hydroxytaxol, the principal human metabolite of taxol J Med Chem 37 1994 706 709 (Pubitemid 24102192)
81. J. Li, M. Zhao, P. He Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes Clin Cancer Res 13 2007 3731 3737 (Pubitemid 46955138)
82. N. Shulman, A. Zolopa, D. Havlir Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia Antimicrob Agents Chemother 46 2002 3907 3916 (Pubitemid 35403268)
83. J. Drewe, H. Gutmann, G. Fricker HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833 J.Biochem Pharmacol 57 1999 1147 1152 (Pubitemid 29171690)
84. G. Moyle, W. Sawyer, M. Law Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies Clin Ther 26 2004 92 97 (Pubitemid 38241526)
85. Chemotherapy for Lung Cancer in HIV-positive patients http://www.clinicaltrials.gov/ct2/results?term=NCT01296113 Accessed: May 11, 2011
86. Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection http://www.clinicaltrials.gov/ct2/results?term=NCT01249443 Accessed: May 11, 2011
87. S. Nahvi, N.A. Cooperman Review: the need for smoking cessation among HIV-positive smokers AIDS Educ Prev 21 2009 14 27
88. Clinical practice guideline Treating tobacco use and dependence: 2008 update. Department of Health and Human Services http://www.surgeongeneral.gov/ tobacco/treating-tobacco-use08.pdf Accessed: May 11, 2011
89. nd edition 2002 The Guilford Press New York
90. R. Niaura, W.G. Shadel, K. Morrow Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now Clinical Infectious Diseases 31 2000 808 812 (Pubitemid 32295508)
91. J.A. Simon, T.P. Carmody, E.S. Hudes Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial Am J Med 114 2003 555 562 (Pubitemid 36577258)
92. L.M. Hesse, L.L. von Moltke, R.I. Shader Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion Drug Metab Dispos 29 2001 100 102 (Pubitemid 32112922)
93. L.M. Hesse, D.J. Greenblatt, L.L. von Moltke Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers Clin Pharmacol 46 2006 567 576
94. L.Y. Park-Wyllie, T. Antoniou Concurrent use of bupropion with CYP2B6 inhibitors, nelfinavir, ritonavir and efavirenz: a case series AIDS 17 2003 638 640 (Pubitemid 36293123)
95. C. Tornero, C. Mafé Varenicline and antiretroviral therapy in patients with HIV J Acquir Immune Defic Syndr 52 2009 656
96. FDA Postmarket Drug Safety Information for Patients and Providers, 2009 www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm169986.htm Accessed: May 11.2011
97. L. Elzi, D. Spoerl, J. Voggensperger Swiss HIV Cohort Study: a smoking cessation programme in HIV-infected individuals: a pilot study Antivir Ther 11 2006 787 795 (Pubitemid 44497174)
98. D. Cummins, G. Trotter, M. Moussa Smoking cessation for clients who are HIV-positive Nursing Standard 20 2005 41 47
99. M.E. Wewers, J.L. Neidig, K.E. Kihm The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers J Assoc Nurses AIDS Care 11 2000 37 44
100. D.J. Vidrine, R.C. Arduino, A.B. Lazev A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS AIDS 20 2006 253 260
101. A. Benard, F. Bonnet, J.F. Tessier Tobacco addiction and HIV infection: toward the implementation of cessation programs ANRS CO3 Aquitaine Cohort AIDS Patient Care STDS 21 2007 458 468 (Pubitemid 47221641)
102. E.M. Mamary, D. Bahrs, S. Martinez Cigarette smoking and the desire to quit among individuals living with HIV AIDS Patient Care STDS 16 2002 39 42 (Pubitemid 34118921)
103. W.F. Velicer, J. Fava, J.O. Prochaska Distribution of smokers by stage in three representative samples Preventive Medicine 24 1996 401 411
104. M. Gopal, S.E. Abdullah, J.J. Grady Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials Thorac Oncol 5 2010 1233
105. B.J. Flehinger, M.R. Melamed, M.B. Zaman Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study Am Rev Respir Dis 130 1984 555 560 (Pubitemid 15200004)
106. M.R. Melamed Lung cancer screening results in the National Cancer Institute New York study Cancer 89 suppl 11 2000 2356 2362
107. M.S. Tockman Survival and mortality from lung cancer in a screened population: The Johns Hopkins Study Chest 89 suppl 1986 324S 325S
108. A.K. Kubík, D.M. Parkin, P. Zatloukal Czech study on lung cancer screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment Cancer 89 suppl 11 2000 2363 2368
109. R.S. Fontana, D.R. Sanderson, L.B. Woolner Screening for lung cancer: a critique of the Mayo Lung Project Cancer 67 suppl 4 1991 1155 1164
110. D.r. Abeele, C.D. Berg National Lung Cancer Research Team The National Lung Screening Trial: Overview and Study Design Radiology 258 2011 243 253
111. Lung cancer trial results show mortality benefit with low-dose CT: Twenty percent fewer lung cancer deaths seen among those who were screened with low-dose spiral CT than with chest X-ray US Department of Health and Human Services, NIH http://www.nih.gov/news/health/nov2010/nci-04.htm Accessed: May11, 2011
112. D.J. Brenner Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer Radiology 231 2004 440 445 A (Pubitemid 38552902)
113. J.M. Croswell, S.G. Baker, P.M. Marcus Kramer cumulative incidence of false-positive test results in lung cancer screening: a randomized trial Ann Intern Med 152 2010 505
114. Early lung cancer diagnosis in HIV infected population with an important smoking history with low dose CT: a pilot study (EP48 HIV CHEST) http://clinicaltrials.gov/ct2/show/NCT01207986 Accessed: May 11, 2011
115. Lung Cancer Screening An Update for the U.S. Preventive Services Task Force www.ahrq.gov/downloads/pub/prevent/pdfser/lungcanser.pdf Accessed: May 11, 2011
116. E.Y. Chiao, B.J. Dezube, S.E. Krown Time for oncologists to opt in for routine opt-out HIV testing? JAMA 304 2010 334 339